Sugar Maple Asset Management »

Jazz Pharmaceuticals shares owned by Sugar Maple Asset Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Sugar Maple Asset Management from 13F filings

Historical chart of Sugar Maple Asset Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Sugar Maple Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Sugar Maple Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $301k 2.5k 120.40

More positions owned by Sugar Maple Asset Management

Ishares Tr TRS FLT RT BD (TFLO)
Abbvie (ABBV)
Ishares Tr Core S&p500 Etf (IVV)
Abbott Laboratories (ABT)
Spdr Gold Tr Gold Shs (GLD)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Msci Usa Min Vol (USMV)
Innovator Etfs Trust Us Eqty Pwr Buf (POCT)
Pacer Fds Tr Pacer Us Small (CALF)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Specialized Funds Div App Etf (VIG)
Fidelity Covington Trust Divid Etf Risi (FDRR)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Goldman Sachs Etf Tr Acces Treasury (GBIL)

View all positions for Sugar Maple Asset Management

Top funds holding Jazz Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
LSV Asset Management
Jpmorgan Chase & Co
Polaris Capital Management
Capital World Investors
Ameriprise Financial
Pacer Advisors
Renaissance Technologies
Camber Capital Management
Geode Capital Management
Hanna Zanoni
EcoR1 Capital
FMR

View all funds holding Jazz Pharmaceuticals